First Niagara Bank’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$231K Sell
2,658
-150
-5% -$12.1K 0.07% 173
2016
Q1
$211K Sell
2,808
-1,891
-40% -$142K 0.06% 181
2015
Q4
$361K Sell
4,699
-3,000
-39% -$226K 0.1% 138
2015
Q3
$516K Buy
7,699
+56
+0.7% +$4.12K 0.14% 128
2015
Q2
$566K Sell
7,643
-4,932
-39% -$377K 0.13% 126
2015
Q1
$981K Buy
12,575
+115
+0.9% +$8.72K 0.22% 101
2014
Q4
$899K Sell
12,460
-7,171
-37% -$498K 0.19% 104
2014
Q3
$1.22M Sell
19,631
-1,450
-7% -$92.2K 0.26% 90
2014
Q2
$1.34M Sell
21,081
-1,085
-5% -$65.9K 0.28% 85
2014
Q1
$1.36M Sell
22,166
-1,510
-6% -$88K 0.27% 88
2013
Q4
$1.36M Sell
23,676
-30
-0.1% -$1.7K 0.26% 88
2013
Q3
$1.26M Sell
23,706
-1,573
-6% -$84.6K 0.27% 86
2013
Q2
$1.3M Buy
+25,279
New +$1.25M 0.27% 82

Other funds holding MDT

First Niagara Bank's MDT Position: Q2 2016 in Review

First Niagara Bank reduced its Medtronic (MDT) stake by 5.3% in Q2 2016, selling an estimated $12.1K and leaving 2,658 shares worth $231K. The position accounts for 0.07% of the portfolio, ranked #173.

First Niagara Bank first reported a position in MDT in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.36M in Q1 2014. 1,263 funds tracked by Wall St. Rank hold MDT as of Q2 2016.

  • First Niagara Bank held 2,658 shares of Medtronic worth $231K as of Q2 2016.
  • First Niagara Bank sold 150 Medtronic shares in Q2 2016, an estimated $12.1K.
  • Medtronic made up 0.07% of First Niagara Bank's portfolio in Q2 2016, its #173 holding.
  • First Niagara Bank first reported a position in Medtronic in Q2 2013 and has held it in 13 quarters since.
  • First Niagara Bank's Medtronic position peaked at $1.36M in Q1 2014.
  • 1,263 funds tracked by Wall St. Rank held Medtronic as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.